APOA1 and atherosclerosis: While lipid biomarkers, such as Apolipoprotein A-I (ApoA-I) and Apolipoprotein B (ApoB), are strongly associated with the development and progression of atherosclerosis, there is no evidence suggesting their ability to differentiate between PR and PE.